Market cap
₹1,146 Cr
Revenue (TTM)
₹168 Cr
P/E Ratio
19.6
P/B Ratio
3.3
Div. Yield
0.4 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 44.16 | 42.41 | 61.07 | 36.21 | 8.89 |
| EBIT | 173.70 | 38.87 | 9.59 | 23.35 | -1.54 |
| Net Profit | 86.69 | 20.96 | 19.37 | 28.43 | 7.03 |
| EPS | 86.70 | 20.96 | 19.37 | 27.16 | 4.24 |
| Book Value | -- | -- | 20.85 | 18.83 | 16.52 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 52.08 | 44.23 | 31.49 | 36.39 | 50.82 |
| Net Margin
| 43.50 | 37.98 | 30.52 | 35.78 | 42.75 |
| Return on equity
| 20.94 | 18.52 | 17.45 | 20.22 | 19.41 |
| Return on Capital
| 28.17 | 24.66 | -- | 25.90 | 26.03 |
| Return on Assets
| 19.03 | 15.74 | 15.95 | 17.79 | 17.54 |
| Debt to Equity (x)
| -- | -- | 0.01 | 0.01 | 0.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
25.90
|
26.03
|
21.21
|
20.24
|
|
Peer Median
|
--
|
16.00
|
12.22
|
21.63
|
--
|
ROE
17.45
Higher than Peers by 6.13
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
17.45
|
20.22
|
19.41
|
15.42
|
14.98
|
|
Peer Median
|
11.32
|
12.35
|
9.23
|
18.08
|
--
|
ROA
15.95
Higher than Peers by 9.01
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
15.95
|
17.79
|
17.54
|
13.89
|
12.77
|
|
Peer Median
|
6.94
|
6.97
|
5.98
|
9.92
|
--
|
EBIT Margin
31.49
Higher than Peers by 22.96
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
31.49
|
36.39
|
50.82
|
43.07
|
45.68
|
|
Peer Median
|
8.53
|
8.77
|
9.68
|
7.64
|
--
|
Net Margin
30.52
Higher than Peers by 24.05
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
30.52
|
35.78
|
42.75
|
37.04
|
37.54
|
|
Peer Median
|
6.47
|
6.25
|
5.63
|
8.97
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
0.00
|
45.84
|
50.56
|
44.73
|
43.34
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
61.07
Higher than Peers by 54.68
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
61.07
|
47.11
|
30.14
|
19.87
|
-23.32
|
|
Peer Median
|
6.39
|
3.57
|
7.71
|
-11.85
|
--
|
EBIT Growth
9.59
Lower than Peers by 1.32
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
9.59
|
5.36
|
53.56
|
13.02
|
-22.45
|
|
Peer Median
|
10.91
|
3.75
|
31.57
|
-36.92
|
--
|
Net Profit Growth
19.37
Higher than Peers by 7.13
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
19.37
|
25.66
|
48.56
|
23.77
|
-19.45
|
|
Peer Median
|
12.24
|
14.74
|
30.59
|
-41.41
|
--
|
EPS Growth
19.37
Higher than Peers by 9.59
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
19.37
|
25.66
|
48.56
|
23.74
|
-29.55
|
|
Peer Median
|
9.78
|
13.24
|
31.07
|
-42.07
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
20.85
|
20.34
|
15.42
|
26.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.01
Lower than Peers by 0.00
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
0.01
|
0.01
|
0.00
|
0.00
|
0.01
|
|
Peer Median
|
0.01
|
0.12
|
0.05
|
0.11
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
--
|
--
|
0.00
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
5.49
Higher than Peers by 3.60
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
5.49
|
5.27
|
7.11
|
7.04
|
8.05
|
|
Peer Median
|
1.89
|
1.78
|
2.07
|
1.63
|
--
|
Quick Ratio
5.02
Higher than Peers by 3.86
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
5.02
|
4.77
|
6.64
|
6.56
|
7.49
|
|
Peer Median
|
1.15
|
1.14
|
1.23
|
1.13
|
--
|
Interest Coverage
224.17
Higher than Peers by 211.06
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
224.17
|
325.63
|
590.84
|
357.08
|
178.97
|
|
Peer Median
|
13.11
|
12.06
|
12.22
|
12.03
|
--
|
Operating Efficiency
Debtors to sales
38.34
Higher than Peers by 5.20
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
38.34
|
35.29
|
37.86
|
48.90
|
54.89
|
|
Peer Median
|
33.14
|
34.10
|
30.54
|
25.72
|
--
|
Asset Turnover
0.45
Lower than Peers by 0.40
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
0.45
|
0.42
|
0.35
|
0.32
|
0.30
|
|
Peer Median
|
0.85
|
0.85
|
0.85
|
0.88
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
111.38
|
137.66
|
172.80
|
188.65
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
34.87
|
32.48
|
40.55
|
45.68
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
45.25
|
42.09
|
61.16
|
70.42
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
--
|
101.00
|
128.05
|
152.20
|
163.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
19.55
Lower than Peers by 0.09
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
19.55
|
16.10
|
29.05
|
20.54
|
13.73
|
|
Peer Median
|
19.64
|
18.68
|
39.81
|
50.05
|
--
|
Price / Book Value
3.30
Higher than Peers by 1.03
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
3.30
|
2.97
|
5.16
|
2.96
|
1.84
|
|
Peer Median
|
2.27
|
2.27
|
4.60
|
3.48
|
--
|
Dividend Yield
0.37
Higher than Peers by 0.04
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
0.37
|
0.44
|
0.25
|
0.39
|
0.60
|
|
Peer Median
|
0.33
|
0.33
|
0.20
|
0.55
|
--
|
EV/EBITDA
12.07
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
12.07
|
10.53
|
20.20
|
13.14
|
8.22
|
|
Peer Median
|
--
|
12.84
|
29.16
|
19.72
|
--
|
Market Cap
1,146
Lower than Peers by 606
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
3B Blackbio Dx
|
1,146
|
965
|
1,385
|
659
|
356
|
|
Peer Median
|
1,752
|
1,752
|
4,155
|
3,052
|
--
|